Login / Signup

Innovative Linker Strategies for Tumor-Targeted Drug Conjugates.

Alberto Dal CorsoLuca PignataroLaura BelvisiCesare Gennari
Published in: Chemistry (Weinheim an der Bergstrasse, Germany) (2019)
The covalent conjugation of potent cytotoxic agents to either macromolecular carriers or small molecules represents a well-known approach to increase the therapeutic index of these drugs, thus improving treatment efficacy and minimizing side effects. In general, cytotoxic activity is displayed only upon cleavage of a specific chemical bond (linker) that connects the drug to the carrier. The perfect balance between the linker stability and its selective cleavage represents the key for success in these therapeutic approaches and the chemical toolbox to reach this goal is continuously expanding. In this Review article, we highlight recent advances on the different modalities to promote the selective release of cytotoxic agents, either by exploiting specific hallmarks of the tumor microenvironment (e.g. pH, enzyme expression) or by the application of external triggers (e.g. light and bioorthogonal reactions).
Keyphrases
  • cancer therapy
  • poor prognosis
  • dna binding
  • drug induced
  • adverse drug
  • emergency department
  • binding protein
  • combination therapy
  • replacement therapy